These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1769023)

  • 61. Design of conformationally rigid dimeric MRI agents.
    Shukla R; Fernandez M; Pillai RK; Ranganathan R; Ratsep PC; Zhang X; Tweedle MF
    Magn Reson Med; 1996 Jun; 35(6):928-31. PubMed ID: 8744023
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Revisiting an old friend: manganese-based MRI contrast agents.
    Pan D; Caruthers SD; Senpan A; Schmieder AH; Wickline SA; Lanza GM
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2011; 3(2):162-73. PubMed ID: 20860051
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Metal-based environment-sensitive MRI contrast agents.
    Bonnet CS; Tóth É
    Curr Opin Chem Biol; 2021 Apr; 61():154-169. PubMed ID: 33706246
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Molecular masking and unmasking of the paramagnetic effect of iron on the proton spin-lattice (T1) relaxation time in blood and blood clots.
    Finnie M; Fullerton GD; Cameron IL
    Magn Reson Imaging; 1986; 4(4):305-10. PubMed ID: 3669945
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Imaging of Transmetallation and Chelation Phenomena Involving Radiological Contrast Agents in Mineral-Rich Fruits.
    Sarkar S; Vinokur Z; Buitrago B; Mousa L; Sanchez H; Basilicata A; Douglas JA; Reddock S
    Tomography; 2022 May; 8(3):1413-1428. PubMed ID: 35645400
    [TBL] [Abstract][Full Text] [Related]  

  • 66. On the relative importance of paramagnetic relaxation and diffusion-mediated susceptibility losses in tissues.
    Kennan RP; Zhong J; Gore JC
    Magn Reson Med; 1991 Dec; 22(2):197-203; discussion 213-5. PubMed ID: 1812346
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Monoclonal antibodies labeled with polymeric paramagnetic ion chelates.
    Shreve P; Aisen AM
    Magn Reson Med; 1986 Apr; 3(2):336-40. PubMed ID: 3713499
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Value of Contrast-enhanced Magnetic Resonance Imaging (MRI) in the Diagnosis of Breast Cancer.
    Gonçalves MA; Pereira BTL; Tavares CA; Santos TMR; da Cunha EFF; Ramalho TC
    Mini Rev Med Chem; 2022; 22(6):865-872. PubMed ID: 34355681
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Using radiotracers to characterize magnetic resonance imaging contrast agents.
    Tweedle MF
    Invest Radiol; 2002 Mar; 37(3):107-13. PubMed ID: 11882789
    [No Abstract]   [Full Text] [Related]  

  • 70. Nanoformulations for molecular MRI.
    Tu C; Louie AY
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2012; 4(4):448-57. PubMed ID: 22488901
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Paramagnetic iron (III) MRI contrast agents.
    White DL
    Magn Reson Med; 1991 Dec; 22(2):309-12. PubMed ID: 1812362
    [No Abstract]   [Full Text] [Related]  

  • 72. Regioselective alkylation and acylation of carbohydrates engaged in metal complexes.
    Eby R; Webster KT; Schuerch C
    Carbohydr Res; 1984 Jul; 129():111-20. PubMed ID: 6467245
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Use of metalloporphyrins in diagnostic imaging.
    Fawwaz R; Bohdiewicz P; Lavallee D; Wang T; Oluwole S; Newhouse J; Alderson P
    Int J Rad Appl Instrum B; 1990; 17(1):65-72. PubMed ID: 2407694
    [No Abstract]   [Full Text] [Related]  

  • 74. Using MRI to Study High Pressure Assisted Nutrient Infusion.
    Kerr JD; Gruber DM; Augustine MP
    Molecules; 2022 Nov; 27(22):. PubMed ID: 36432073
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Copper-D-penicillamine complex as potential contrast agent for MRI.
    Kupka T; Dziegielewski JO; Pasterna G; Małecki JG
    Magn Reson Imaging; 1992; 10(5):855-8. PubMed ID: 1461082
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Properties of paramagnetic metals in MRI.
    Schaefer M
    Met Based Drugs; 1997; 4(3):159-71. PubMed ID: 18475786
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Paramagnetic Relaxation Agents for Enhancing Temporal Resolution and Sensitivity in Multinuclear FlowNMR Spectroscopy.
    Bara-Estaún A; Harder MC; Lyall CL; Lowe JP; Suturina E; Hintermair U
    Chemistry; 2023 Jul; 29(38):e202300215. PubMed ID: 36946535
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Development of fluorescence/MR dual-modal manganese-nitrogen-doped carbon nanosheets as an efficient contrast agent for targeted ovarian carcinoma imaging.
    Han C; Xie T; Wang K; Jin S; Li K; Dou P; Yu N; Xu K
    J Nanobiotechnology; 2020 Nov; 18(1):175. PubMed ID: 33256741
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Gd
    Mondjinou YA; Loren BP; Collins CJ; Hyun SH; Demoret A; Skulsky J; Chaplain C; Badwaik V; Thompson DH
    Bioconjug Chem; 2018 Nov; 29(11):3550-3560. PubMed ID: 30403467
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Manganese-based MRI contrast agents: past, present and future.
    Pan D; Schmieder AH; Wickline SA; Lanza GM
    Tetrahedron; 2011 Nov; 67(44):8431-8444. PubMed ID: 22043109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.